No, LC design them for a T/O with Fast Track designation, ODD and registrational clinical trial path to minimise the timeframe to commercialisation and making the IP very attractive to BP as she has done all the hard work for them.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)